Pradaxa Antidote Found Extremely Effective

 Pradaxa antidote looks promising for those with uncontrolled or life-threatening bleeding complications. Read more

High Levels of Diacetyl Found at Wisconsin Coffee Plant

 

The U.S. Centers for Disease Control and Prevention (CDC) is examining health hazards faced by some 600,000 employees nationwide who work in businesses that roast, grind, package, and serve coffee. The CDC’s first test results from Just Coffee, a midsize coffee roasting facility in Madison, Wisconsin, found extremely high levels of two lung-destroying… Read more »

Bard Canada Agrees Settle Mesh Cases for $2.4 Million

 

Three Canadian women who allege that they suffered complications from the transvaginal mesh they had implanted to treat pelvic organ prolapse (POP) and female stress urinary incontinence (SUI) have reached a $2.4 million settlement with Bard Canada.  Read more »

Pradaxa Antidote Found Extremely Effective

 

 Pradaxa antidote looks promising for those with uncontrolled or life-threatening bleeding complications. Read more »

CDC: Coffee Bean Fumes Dangerous to Workers’ Health

 

Federal investigators are currently conducting tests at approximately one dozen facilities across the U.S., in response to a probe by the Milwaukee Journal Sentinel that exposed how a naturally occurring chemical actually endangers the health of coffee workers. When coffee beans are roasted, two chemicals, diacetyl and 2,3-pentanedione, form and… Read more »

Cutting Their Losses: Endo to Stop Making AMS Transvaginal Mesh

 

Effective March 31, 2016, Endo International will close its Astora Women’s Health device unit, and will cease the production and marketing of American Medical Systems (AMS) transvaginal mesh implants. The closure is seen as an effort by Endo to reduce future fallout from soaring legal costs and large settlements paid to injured women through… Read more »

FDA Refuses to Pull Essure Off Market Amid Criticism

 

After six months of deliberation over thousands of complaints regarding side effects associated with the permanent birth control device Essure, the U.S. Food and Drug Administration (FDA) did not pull the device from the market, as many had hoped it would.   Instead, the FDA ordered Essure’s manufacturer, Bayer, to launch new clinical… Read more »

Missouri Jury Sides With Defendant in Complicated Transvaginal Mesh Case

 

On February 4, 2016 a Missouri jury returned a 10-2 verdict in favor of transvaginal mesh manufacturers Boston Scientific and C.R. Bard. The lawsuit was brought by Eve Sherrer, a woman who wanted a solution to mild urinary incontinence but instead found a nightmare. Ms. Sherrer underwent her first surgery to treat mild urinary incontinence issues.… Read more »

Jury Awards $13.5 Million in Second Ethicon Transvaginal Mesh Case in Philadelphia

 

The second Ethicon transvaginal mesh trial to get to jury in Philadelphia ends in a $13.5 million verdict.  The first trial also ended in a plaintiff's verdict in the amount of $12.5 million.  THL is pleased with this verdict and looks forward to continuing to fight vigorously for all of our clients injured by transvaginal mesh devices.   Read more »

E-Cigarette Legislation Protecting Children Signed Into Law

 

E-cigarettes are adult products that should be kept out of the hands of children. That is the focus of legislation that recently passed both the U.S. House and Senate that will potentially save the lives of many children, as the debate regarding the regulation of the e-cigarette industry continues.   President Obama signed the Child Nicotine… Read more »

FDA Examines Risks and Benefits of Fluoroquinolones

 

TorHoerman Law is currently investigating the possibility of filing FQAD lawsuits on behalf of previously healthy individuals that experience a “constellation of symptoms” across multiple body parts and believe their fluoroquinolone might be to blame. Read more »

Federal Appellate Court Approves $2 Million Verdict For Vaginal Mesh Victim

 

All in all, the federal appellate court's decision is a tremendous victory for women nationwide. The appellate court completely rejected all of the mesh manufacturer's complaints about the trial, thereby affirming the right of other injured women to present the same type of evidence in their trials. TorHoerman Law is still fighting hard for women injured by transvaginal mesh, including by getting several of our own “bellwether” cases ready for trial. Read more »

Kentucky Risperdal Claim Settled for $15.5M

 

On December 22, 2015, Janssen Pharmaceuticals and its parent company, Johnson & Johnson, entered into a settlement with the Commonwealth of Kentucky, agreeing to pay $15.5 million to the state, sufficiently disclose the associated risks of the drug, and cease the company’s promotion of Risperdal for non-FDA approved uses. Read more »

Low Dose Radiation Significantly Increases Risk of Solid Cancer, According to Recent Large Study

 

This week the esteemed British Medical Journal (BMJ) published an editorial discussing the findings of a large (>300,000 subjects) cohort study confirming that extended exposure to even low dose ionizing radiation significantly increases a person’s risk of cancer.  Read more »

Benicar MDL Established in New Jersey - Cases Move Forward

 

A federal judicial panel has granted a request to consolidate lawsuits claiming that blood-pressure medication Benicar could cause severe gastrointestinal injuries. Read more »

We Pledge Allegiance to Local Food - Will You Join Us?

 

TorHoerman Law is proud to announce its partnership with Grassroots Grocery through their “corporate membership” program that will promote local sustainable food for all of our community and encourage the THL staff to eat healthy while supporting the local economy. Read more »

 

1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21   Next »

No-Obligation Free Consultation

Contact us by phone at (618) 656-4400 or email us below.


 

Your information will be used only so that we may contact you to evaluate your case. Your contact information will never be shared or sold to anyone other than TorHoerman Law.